Search alternatives:
marker decrease » marked decrease (Expand Search), larger decrease (Expand Search), markedly decreased (Expand Search)
i marked » _ marked (Expand Search), _ market (Expand Search), _ marker (Expand Search)
3 marker » _ marker (Expand Search), _ markers (Expand Search)
a marked » _ marked (Expand Search), a market (Expand Search), _ market (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
increase » increased (Expand Search)
marker decrease » marked decrease (Expand Search), larger decrease (Expand Search), markedly decreased (Expand Search)
i marked » _ marked (Expand Search), _ market (Expand Search), _ marker (Expand Search)
3 marker » _ marker (Expand Search), _ markers (Expand Search)
a marked » _ marked (Expand Search), a market (Expand Search), _ market (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
increase » increased (Expand Search)
-
1
-
2
Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx
Published 2020“…Increased CRP, CCL2, and IL1RA, and decreased KA and KA/Kyn are trait markers of psychotic illness.…”
-
3
The proportion of ALDH+ cells progressively increases while CGA+ cells markedly decreases in <i>APC</i>-mutant colon tissues from FAP patients.
Published 2020“…Results show that, in normal crypts, the distribution and proportion of cells staining for ALDH1 and CGA are very similar. In contrast, in <i>APC</i>-mutant tissues from FAP patients, the proportion of ALDH+ cells progressively increases while CGA+ cells markedly decreases. …”
-
4
-
5
-
6
-
7
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…Summarized bar graphs showed EVO significantly decreased mRNA expression of pyroptotic markers (B) NLRP3 and (C) GSDM-D in CER treated P<sub>i</sub>-induced VSMCs. …”
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice.
Published 2022“…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”
-
17
-
18
-
19
-
20